KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Other financing activities (2020 - 2025)

Historic Other financing activities for Bionano Genomics (BNGO) over the last 6 years, with Q3 2025 value amounting to $969000.0.

  • Bionano Genomics' Other financing activities rose 13299.28% to $969000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 5676.1%. This contributed to the annual value of $3.0 million for FY2024, which is 3468.26% down from last year.
  • Per Bionano Genomics' latest filing, its Other financing activities stood at $969000.0 for Q3 2025, which was up 13299.28% from $104000.0 recorded in Q2 2025.
  • Bionano Genomics' 5-year Other financing activities high stood at $5.0 million for Q2 2024, and its period low was -$2.9 million during Q3 2024.
  • Its 5-year average for Other financing activities is $783200.0, with a median of $515000.0 in 2024.
  • Data for Bionano Genomics' Other financing activities shows a peak YoY increase of 99168.49% (in 2024) and a maximum YoY decrease of 100648.15% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Bionano Genomics' Other financing activities stood at $555000.0 in 2021, then grew by 4.14% to $578000.0 in 2022, then surged by 481.31% to $3.4 million in 2023, then plummeted by 84.67% to $515000.0 in 2024, then surged by 88.16% to $969000.0 in 2025.
  • Its Other financing activities stands at $969000.0 for Q3 2025, versus $104000.0 for Q2 2025 and $919000.0 for Q1 2025.